News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Carlos Moreira, IMS Health Managed Markets Service

Advertisement

Articles by Carlos Moreira, IMS Health Managed Markets Service

A Data-Driven Approach to Contract Performance Monitoring and Analysis

ByJoseph Coppola,Carlos Moreira, IMS Health Managed Markets Service
May 4th 2009

Better use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively

Advertisement

Latest Updated Articles

  • A Data-Driven Approach to Contract Performance Monitoring and Analysis
    A Data-Driven Approach to Contract Performance Monitoring and Analysis

    Published: May 4th 2009 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Trade & Channel Strategies 2025: Channel Strategies Evolve, With Industry Leaders Pushing Toward Faster, More Connected Patient Access

2

Trade & Channel Strategies 2025: How Regulatory & Patent Cliff Disruption is Remaking Pharma Channels

3

HTI-4 Standards Target Lack of Transparency in Medication Access

4

Pharma Pulse: Lilly’s Jaypirca Challenges Imbruvica, as AI Chatbots Could Prove Key to Boosting Vaccine Rates

5

Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us